Author

Haiyun Wang

Tongji UniversityORCID 0000-0001-8364-8328Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Jie ZhengiD· 2 shared Tao WuiD· 2 shared Yue XuiD· 2 shared Bingyue ZhangiD· 1 shared Chiara AmbrogioiD· 1 shared Fan ZhangiD· 1 shared Jens KöhleriD· 1 shared Keying Qiao· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Jie ZhengORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsAdvanced SciencePeer-reviewedNov 19, 2024

scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancers

Peng Tian, Jie Zheng, Keying Qiao…·Haiyun Wang

scPharm integrates pharmacogenomics profiles with scRNA-seq data to identify drug-sensitive subpopulations in cancer tissues and predict combination therapies.

2 citations

humanmouse

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMar 2, 2021

Drug-driven reclassification of multiple tumour subtypes reveals intrinsic molecular concordance of therapy across histologically disparate cancers

Yue Xu, Jie Zheng, Zhaoqing Cai…·Haiyun Wang

This study reclassifies tumors based on drug response and genomic alterations, revealing molecular concordance in therapy across histologically different cancers.

DOI 10.1101/2021.03.02.433516

humanbulk RNA-seq

𝕏 PostBluesky